GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Cyclically Adjusted PS Ratio

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Cyclically Adjusted PS Ratio : 0.21 (As of May. 09, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Cyclically Adjusted PS Ratio?

As of today (2025-05-09), Wanbangde Pharmaceutical Holding Group Co's current share price is ¥5.78. Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥28.17. Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio for today is 0.21.

The historical rank and industry rank for Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:002082' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.12   Med: 0.23   Max: 0.58
Current: 0.21

During the past years, Wanbangde Pharmaceutical Holding Group Co's highest Cyclically Adjusted PS Ratio was 0.58. The lowest was 0.12. And the median was 0.23.

SZSE:002082's Cyclically Adjusted PS Ratio is ranked better than
94.15% of 735 companies
in the Drug Manufacturers industry
Industry Median: 2.02 vs SZSE:002082: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Wanbangde Pharmaceutical Holding Group Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.516. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥28.17 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Wanbangde Pharmaceutical Holding Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Cyclically Adjusted PS Ratio Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.33 0.22 0.19 0.22

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.13 0.16 0.22 0.21

Competitive Comparison of Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio falls into.


;
;

Wanbangde Pharmaceutical Holding Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.78/28.17
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Wanbangde Pharmaceutical Holding Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.516/115.1156*115.1156
=0.516

Current CPI (Mar. 2025) = 115.1156.

Wanbangde Pharmaceutical Holding Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 12.444 99.500 14.397
201509 14.055 100.500 16.099
201512 12.449 100.600 14.245
201603 7.497 102.200 8.444
201606 7.918 101.400 8.989
201609 9.958 102.400 11.195
201612 12.648 102.600 14.191
201703 10.869 103.200 12.124
201706 12.833 103.100 14.329
201709 17.032 104.100 18.834
201712 20.412 104.500 22.486
201803 11.754 105.300 12.850
201806 14.238 104.900 15.625
201809 15.108 106.600 16.315
201812 16.317 106.500 17.637
201903 5.338 107.700 5.706
201906 7.887 107.700 8.430
201909 6.881 109.800 7.214
201912 8.457 111.200 8.755
202003 4.285 112.300 4.392
202006 6.799 110.400 7.089
202009 6.556 111.700 6.756
202012 4.063 111.500 4.195
202103 0.844 112.662 0.862
202106 0.621 111.769 0.640
202109 0.633 112.215 0.649
202112 0.992 113.108 1.010
202203 0.537 114.335 0.541
202206 0.647 114.558 0.650
202209 0.732 115.339 0.731
202212 0.951 115.116 0.951
202303 0.623 115.116 0.623
202306 0.581 114.558 0.584
202309 0.461 115.339 0.460
202312 0.835 114.781 0.837
202403 0.693 115.227 0.692
202406 0.526 114.781 0.528
202409 0.522 115.785 0.519
202412 0.601 114.893 0.602
202503 0.516 115.116 0.516

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Wanbangde Pharmaceutical Holding Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines